ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
LONG-TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT)
Hematological Oncology
◽
10.1002/hon.65_2630
◽
2019
◽
Vol 37
◽
pp. 256-257
Author(s):
A.J. Ferreri
◽
M.C. Sassone
◽
P. Angelillo
◽
F. Zaja
◽
A. Re
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
Autologous Transplantation
◽
B Cell Lymphoma
◽
Efficacy And Safety
◽
Term Efficacy
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Related Documents
Cited By
References
Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients
Hematological Oncology
◽
10.1002/hon.2049
◽
2013
◽
Vol 31
(4)
◽
pp. 223-224
◽
Cited By ~ 19
Author(s):
Pier Luigi Zinzani
◽
Cinzia Pellegrini
◽
Enrico Derenzini
◽
Lisa Argnani
◽
Stefano Pileri
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Term Efficacy
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Review for "LONG-LASTING EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR OR FAILED AUTOLOGOUS TRANSPLANTATION"
10.1002/hon.2742/v1/review1
◽
2020
◽
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
Autologous Transplantation
◽
B Cell Lymphoma
◽
Efficacy And Safety
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Decision letter for "LONG-LASTING EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR OR FAILED AUTOLOGOUS TRANSPLANTATION"
10.1002/hon.2742/v1/decision1
◽
2020
◽
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
Autologous Transplantation
◽
B Cell Lymphoma
◽
Efficacy And Safety
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantation
Hematological Oncology
◽
10.1002/hon.2742
◽
2020
◽
Vol 38
(3)
◽
pp. 257-265
Author(s):
Andrés J. M. Ferreri
◽
Marianna Sassone
◽
Piera Angelillo
◽
Francesco Zaja
◽
Alessandro Re
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
Autologous Transplantation
◽
B Cell Lymphoma
◽
Efficacy And Safety
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Author response for "LONG-LASTING EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR OR FAILED AUTOLOGOUS TRANSPLANTATION"
10.1002/hon.2742/v2/response1
◽
2020
◽
Author(s):
Andrés J. M. Ferreri
◽
Marianna Sassone
◽
Piera Angelillo
◽
Francesco Zaja
◽
Alessandro Re
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
Autologous Transplantation
◽
B Cell Lymphoma
◽
Author Response
◽
Efficacy And Safety
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Decision letter for "LONG-LASTING EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR OR FAILED AUTOLOGOUS TRANSPLANTATION"
10.1002/hon.2742/v2/decision1
◽
2020
◽
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
Autologous Transplantation
◽
B Cell Lymphoma
◽
Efficacy And Safety
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
Hematological Oncology
◽
10.1002/hon.28_2879
◽
2021
◽
Vol 39
(S2)
◽
Author(s):
J Duell
◽
K. J Maddocks
◽
E González‐Barca
◽
W Jurczak
◽
A. M Liberati
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Phase Ii Study
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Long-Term Survival and Gradual Recovery of B Cells in Patients (Pts) with Refractory Large B Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel (Axi-Cel)
Transplantation and Cellular Therapy
◽
10.1016/s2666-6367(21)00520-0
◽
2021
◽
Vol 27
(3)
◽
pp. S404-S405
Author(s):
Caron A. Jacobson
◽
Frederick L. Locke
◽
Armin Ghobadi
◽
David B. Miklos
◽
Lazaros J. Lekakis
◽
...
Keyword(s):
B Cells
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Term Survival
◽
Long Term Survival
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial
Advances in Therapy
◽
10.1007/s12325-020-01603-8
◽
2021
◽
Vol 38
(4)
◽
pp. 1889-1903
Author(s):
Yuqin Song
◽
Hui Zhou
◽
Huilai Zhang
◽
Wei Liu
◽
Yuerong Shuang
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
Large B Cell Lymphoma
◽
Parallel Group
◽
Large B Cell
Download Full-text
ESTIMATION OF LONG‐TERM SURVIVAL WITH TAFASITAMAB + LENALIDOMIDE (LEN) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
Hematological Oncology
◽
10.1002/hon.89_2880
◽
2021
◽
Vol 39
(S2)
◽
Author(s):
G Salles
◽
B Goswami
◽
V Bagnardi
◽
D Dey
◽
M Winderlich
◽
...
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Term Survival
◽
Long Term Survival
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close